Latest News
From the Journals
New data dissect global burden of scabies
Children and teens are most affected.
Conference Coverage
New psoriasis therapies coming of age
Interleukin-23 and interleukin-17 are promising targets in the treatment of moderate to severe plaque psoriasis.
Conference Coverage
Rosacea: Expert recommends treating erythema, papules/pustules simultaneously
A new study indicates that treatment with both ivermectin and brimonidine simultaneously is beneficial.
Conference Coverage
Old and newer systemic therapies benefit patients with chronic eczema
Dr. Joseph Fowler reviews existing and newer medications available for treating eczema that does not respond to topical agents.
Conference Coverage
Working up patients with allergic contact dermatitis
Patch testing is best done while patients are off immunosuppressants, but current immunosuppressive therapy should not prevent testing.
Conference Coverage
In the reemergence of typhus, the challenge is early diagnosis
SAN DIEGO – Doxycycline is the drug of choice for almost all of the rickettsial infections.
News
FDA approves third indication for onabotulinumtoxinA
The product is now approved for use in improving the appearance of forehead lines
From the Journals
Clinicians persist in prescribing antibiotics for acne
The analysis identified a marked increase in spironolactone prescribing among women with acne, by dermatologists and nondermatologists.
Conference Coverage
High percentage of nursing home residents found to harbor MDROs
SAN DIEGO – About one of every two nursing home residents is colonized with multidrug resistant organisms, according to a large surveillance study...
Feature
MIPS: It’s time to get started
Pick Your Pace offers a way to get started with Medicare’s new QPP and ready physicians for meaningful quality improvement, AMA President David O...
Feature
HCA is the country’s highest-volume health system
The Nashville, Tenn.–based corporation discharged twice as many patients as any other health system in 2016.